Ypsomed Holding AG
YPSN
Rang in aandelen
#2948
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and... Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Aandeelprijs
$469.39
Marktkapitalisatie
$6.17B
Verandering (1 dag)
1.63%
Verandering (1 jaar)
18.98%
Land
CH
Handel Ypsomed Holding AG (YPSN)
Categorie
Healthcare
Omzet van Ypsomed Holding AG (YPSN)
Omzet in Oct 2026 TTM: 0
Volgens de laatste financiële rapporten van Ypsomed Holding AG bedraagt de huidige omzet van het bedrijf (TTM) 0. In 2026 behaalde het bedrijf een omzet van 0 gelijk aan de omzet in het jaar 2026, die 0 bedroeg. De omzet is het totale bedrag aan inkomsten dat een bedrijf genereert door de verkoop van goederen of diensten. In tegenstelling tot de winst worden er geen kosten afgetrokken.
Omzetgeschiedenis van Ypsomed Holding AG van 2002 tot 2026
Omzet aan het einde van elk jaar
| Jaar | Omzet | Wijzigen |
|---|---|---|
| 2025 | $847.04M | 39.34% |
| 2024 | $607.88M | 11.82% |
| 2023 | $543.61M | 7.97% |
| 2022 | $503.49M | 17.75% |
| 2021 | $427.58M | 4.29% |
| 2020 | $409.99M | -10.08% |
| 2019 | $455.95M | -6.76% |
| 2018 | $489.00M | 25.91% |
| 2017 | $388.37M | 10.90% |
| 2016 | $350.19M | 10.82% |
| 2015 | $316.01M | 1.22% |
| 2014 | $312.21M | 21.22% |
| 2013 | $257.56M | -6.31% |
| 2012 | $274.90M | 3.86% |
| 2011 | $264.69M | 9.99% |
| 2010 | $240.64M | 0.57% |
| 2009 | $239.28M | -17.28% |
| 2008 | $289.26M | 26.94% |
| 2007 | $227.87M | -4.32% |
| 2006 | $238.15M | 17.72% |
| 2005 | $202.31M | 38.65% |
| 2004 | $145.92M | 43.99% |
| 2003 | $101.34M | 69.52% |
| 2002 | $59.78M | 0.00% |
Omzet van vergelijkbare bedrijven of concurrenten
| Bedrijf | Omzet | Omzetverschil | Land |
|---|---|---|---|
| $6.04B | - |
IE
|
|
| - | - |
CN
|
|
| - | - |
CH
|
|
| - | - |
CN
|
|
| $352.16M | - |
KR
|
